Eton Park Capital Management’s Allergan plc AGN Stock Holding History

Eton Park Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,875,073	Closed	-$503M	–	48
2016 Q1	$503M	Buy	1,875,073 +926,504	+98%	+$265M	6.14%	5
2015 Q4	$296M	Buy	+948,569	New	+$282M	4.67%	6
2015 Q1	–	Sell	-332,850	Closed	-$85.7M	–	64
2014 Q4	$85.7M	Sell	332,850 -526,150	-61%	-$132M	1.21%	29
2014 Q3	$207M	Buy	859,000 +167,000	+24%	+$37.4M	2.44%	10
2014 Q2	$154M	Buy	692,000 +192,000	+38%	+$39.8M	2.3%	14
2014 Q1	$103M	Hold	500,000	–	–	1.75%	21
2013 Q4	$84M	Hold	500,000	–	–	1.57%	25
2013 Q3	$72M	Hold	500,000	–	–	1.6%	25
2013 Q2	$63.1M	Buy	+500,000	New	+$56.6M	1.21%	25

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Eton Park Capital Management's AGN Position: Q2 2016 in Review

Eton Park Capital Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 1,875,073 shares — an estimated $503M sold.

Eton Park Capital Management first reported a position in AGN in Q2 2013 and held it in 9 quarters. The position peaked at $503M in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Eton Park Capital Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
Eton Park Capital Management sold 1,875,073 Allergan plc shares in Q2 2016, an estimated $503M.
Eton Park Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 9 quarters.
Eton Park Capital Management's Allergan plc position peaked at $503M in Q1 2016.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Eton Park Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.